According to our new research study on “Decapping System Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product, and End User,” the market was valued at US$ 284.67 million in 2022 and is expected to reach US$ 383.25 million by 2028; it is estimated to grow at a CAGR 5.1% from 2022 to 2028.
Factors driving the market growth are the accelerated demand for vaccine egg decapper in the process industry and innovative product launches. However, technical errors and repetitive manual tasks associated with the decapping system are hindering the market growth.
Various companies are developing innovative technologies for decapping of specimen collection tubes. The Pluggo decapper is one example where an automated system is utilized to safely remove stoppers from the standard vacuum blood collection tubes. Additionally, Aim Lab Automation Technologies (Aim Lab), a pioneer in manufacturing specialist laboratory automation robotics, assists in managing a large number of samples before analysis across industrial and pathological laboratories. The company's Tube Decapper Module is an example of technology used to automate the pre-analytical function of decapping a specimen collection tube to incorporate an in-vitro diagnostic (IVD) analyzer or automation system by eliminating complexity. The Tube Decapper Module is fully electric and compact, designed explicitly for decapping a wide range of sample collection tubes comprising screw caps, push-on caps, and conventional rubber bungs that are generally incapable of decapping through commercially available decappers. BD, Greiner, and Sarsedt are a few manufacturers that have decapped tubes from Aim Lab. Such technological advancements are expected to provide lucrative opportunities for the decapping system market growth during the forecast period.
Decapping System Market, by Region, 2022 (%)
Decapping System Market Forecast to 2028 - Global Analysis by Type (Manual, Semi-Automated, and Automated), Application (Tubes and Vials), and End User (Pharmaceutical & Biotech Industry, CDMOs/CROs, and Others)
Decapping System Market Share Report | Global Scenario 2022-2028
Download Free Sample
Source: The Insight Partners Analysis
Based on type, the global decapping system market is segmented into manual, semi-automated, and automated. In 2022, the automated segment held the largest market share and is anticipated to register the highest CAGR of 5.6% during the forecast period. The major driving factor for the growth of the automated segment is the rising demand for higher sampling output in laboratories, as automated decappers save user’s time and effort. Over the years, better and more convenient devices and tools have been developed to productively unscrew and tighten tube caps.
Based on application, the global decapping system market is bifurcated into tubes and vials. The tube segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.
Based on end user, the decapping system market is segmented into pharmaceutical & biotech industry, CDMOs/CROs, and others. The pharmaceutical & biotech industry segment held the largest share of the market in 2022. However, the CDMOs/CROs segment is anticipated to register the highest CAGR of 5.5% in the market during the forecast period.
The COVID-19 pandemic had a moderate impact on the decapping system market. The pandemic changed the overall operation of biopharma companies in China by putting short-term pressure on budget allocation, reducing treatment of non-COVID patients, and undermining market fundamentals. Also, China is the world's second-largest market pharmaceutical market, with the presence of top competitive players. Amid the pandemic, product approvals continued, but launches faced many challenges resulting in fewer diagnoses. Further, drug development significantly increased amid the pandemic, with continued production in manufacturing facilities. Hence, with rising manufacturing facilities and procurement, the demand for decapping systems was high, which fueled the overall market growth.
A few prominent players operating in the decapping system market are Hamilton Co, LVL Technologies GmbH & Co KG, Micronic Holding BV, Sarstedt AG and Co KG, Thermo Fisher Scientific Inc, Azenta Inc, Dominique Dutscher SAS, Cole-Parmer Instrument Co LLC, Agilent Technologies Inc, and AltemisLab, among others.
Companies are launching new and innovative products and services to sustain their position in the decapping system market. In July 2022, Rhinostics and Azenta Life Sciences entered a partnership to provide decapping solutions for RHINOstic automated swab workflows. This solution focuses on the combination of the RHINOstic® Automated Swab and IntelliXcap™ Automated Screw Cap Decapper/Recapper 96-format.
The report segments the global decapping system market as follows:
Based on type, the decapping system market is segmented into manual, semi-automated, and automated. Based on application, the decapping system market is bifurcated into tubes and vials. By end user, the decapping system market is segmented into Pharmaceutical & Biotech Industry, CDMOs/CROs, and Others. By geography, the decapping system market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com